Clinical Trial to Evaluate the Safety and Efficacy of SCAI-001 Compared to Restasis

NCT05733624 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

116

Enrollment

INDUSTRY

Sponsor class

Conditions

Dry Eye Syndromes

Interventions

DRUG: SCAI-001 0.01% eyedrop
DRUG: SCAI-001 0.02% eyedrop
DRUG: Restasis 0.05% eyedrop

Sponsor

SCAI Therapeutics